A study published in 2009 issue of Gastroenterology scientific journal reported only one in 100,000 people have gastroparesis (Jung HK, Choung RS, Locke GR III, et al
People may microdose GLP-1 medications for many reasons, including: They have hit their target weight goal They have concerns about the cost of the medications They are sensitive to the side effects of the medications They want to just suppress their appetite They are worried about the supply of the medications Microdosing GLP-1 medications can come with real risks, including: Inaccurate doses Reduced effectiveness Unpredictable outcomes Possibility of regaining weight No data on the long-term effects of microdosing Minimal oversight Large clinical trials have confirmed that the standard GLP-1 doses work well when helping people lose weight and manage Type 2 diabetes
In order to test anticancer activity, rhodostomin from venom of Calloselasma rhodostoma Trigramin from venom of T
First, there's the obvious: needle aversion
Neither includes genetic pathway testing in standard care
(Primary source for heart rate data) Ilkiw JL, Charman SA, Gao X, et al